Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 19.3.2020Mylan Ireland Limited (MNY)2342BAcamprosat Mylan 333 mg (tbl ent 84x333 mg (blis.PVC))20.3.2020O
 20.12.2024Mylan Ireland Limited (MNY)2342BAcamprosat Mylan 333 mg (tbl ent 84x333 mg (blis.PVC))13.1.2025R
 25.4.2025Mylan Ireland Limited (MNY)2342BAcamprosat Mylan 333 mg (tbl ent 84x333 mg (blis.PVC))28.4.2025O
 12.11.2019Mylan Ireland Limited (MNY)2342BAcamprosat Mylan 333 mg (tbl ent 84x333 mg (blis.PVC))12.11.2019R
 30.6.2022Mylan Ireland Limited (MNY)2342BAcamprosat Mylan 333 mg (tbl ent 84x333 mg (blis.PVC))4.7.2022R
 3.4.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2930AACC 20 mg/ml perorálny roztok pre deti a dospelých (sol por 1x100 ml (fľ.skl.hnedá+striekačka))22.3.2024R
 4.2.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))31.1.2025R
 25.3.2020Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))1.4.2020R
 7.3.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))25.2.2022O
 17.12.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))20.12.2021R
 7.5.2020Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))7.5.2020O
 4.3.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)88939ACC injekt (sol inj 5x3 ml/300 mg (amp.skl.))4.3.2025O
 2.3.2023MEDOCHEMIE Ltd. (MOE)46761ACCEL 10 mg (tbl 30x10 mg)1.5.2023Z
 26.1.2021MEDOCHEMIE Ltd. (MOE)46761ACCEL 10 mg (tbl 30x10 mg)1.2.2021R
 1.4.2021MEDOCHEMIE Ltd. (MOE)46761ACCEL 10 mg (tbl 30x10 mg)1.4.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)